The United States Patent and Trademark Office (USPTO) has Selected Atlanta for its New Regional Office

New regional office and community outreach office to serve as innovation centers for local/regional innovators WASHINGTON— The U.S. Patent and Trademark Office (USPTO) today announced that it will open a new regional office in the Atlanta, Georgia metropolitan area serving innovators in the Southeast region, and a new community outreach office in Strafford County, New…

Read More

As Georgia Tech’s Science Square nears completion, it seeks more tenants

From university spinoffs to publicly traded life science companies, activity is swirling around Georgia Tech’s $1 billion development Science Square. But with the 18-acre project’s completion set for March leasing has been slow. Venture capital company Portal Innovations is building out 33,000 square feet of lab and office space. Otherwise, no leases have been signed.…

Read More

SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-MTM for the Treatment of Solid Tumors

HUMMELSTOWN, Pa., Dec. 12, 2023 (GLOBE NEWSWIRE) — SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for the Company’s lead product candidate, SIRPant-M™,…

Read More

AdvaMed Announces Formation of Medical Imaging Division

World’s largest medical imaging companies join world’s largest medtech association WASHINGTON, D.C., – Today, AdvaMed, the Medtech Association, announced the establishment of a new Medical Imaging Technology division focused on advocating on behalf of large and small companies for the essential role of medical imaging technology, radiopharmaceuticals, contrast media, and focused ultrasound devices in our nation’s health care…

Read More

Using March-In as a Price Control Mechanism Is a “Dangerous Precedent To Set”

The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO’s Chief Advocacy Officer, Nick Shipley, made the following statement: “Using the Bayh-Dole Act’s march-in process as a mechanism…

Read More

Large Majority of Americans Say Consideration of Clinical Trial Participation Should be a Part of Regular Health Care

New National Public Opinion Survey Reveals Willingness to Participate in Clinical Trials; Importance of Trials Reflecting the Population; Concerns About Sharing Personal Health Information Have Grown   Arlington, VA – December 5, 2023 – According to survey findings released today, an overwhelming majority of Americans (87%) agree that health care professionals should discuss clinical trials…

Read More

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023 November 16 2023, ATLANTA– Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines.  The manufacturing facility will…

Read More

Echoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast

In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…

Read More